drugset / Trial / NCT01514422
Minocycline for Bipolar Depression
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate minocycline as a potential treatment for bipolar depression when added to a mood-stabilizing medication. Minocycline is an antibiotic that is approved for the treatment of infections and acne. Participation in this research study is expected to last 8 weeks, and includes five outpatient visits.
Timeline
- Start
- 2011-05
- Primary completion
- 2013-08
- Completion
- 2013-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Minocycline | Small molecule | 100 mg | — |
| Subject | Minocycline | Small molecule | 300 mg | — |